Alloy Therapeutics
Waltham, MA, United States alloytx.com From their website, Nov 2026
Work here? Claim this listing
About
Alloy Therapeutics develops and provides discovery and development platforms for antibody, multispecific, TCR mimic, genetic medicine, pharmacology, and cell therapy programs. It works with biotech innovators, pharma, academic founders, and sovereign organizations worldwide from sites in Waltham, Massachusetts; Athens, Georgia; Cambridge, UK; Basel, Switzerland; and Fujisawa, Japan.
Services
Antibody platforms
Licenses fully human transgenic mouse platforms for human monoclonal antibody discovery, including strains for kappa, lambda, hyperimmune, and common light-chain programs.
Antibody discovery services
Runs end-to-end monoclonal antibody discovery campaigns using immunization, B cell enrichment, deep sequencing, AI/ML repertoire mining, and downstream characterization.
Multispecific antibody discovery
Provides integrated multispecific discovery, engineering, screening, and optimization from binding arm discovery through functional lead selection.
Antibody optimization
Optimizes antibody leads for affinity, specificity, Fc effector function, stability, immunogenicity, and developability using AI/ML and high-throughput testing.
TCR mimic discovery
Discovers TCR mimic antibodies that target intracellular peptides presented on pMHC complexes.
AntiClastic cyclic oligonucleotide platform
Designs and develops cyclic ASO, siRNA, and sgRNA candidates through AI-guided sequence design, optimization, and development candidate selection.
Pharmacology
Provides pharmacology support as part of its integrated product development organization.
Cell therapies
Offers cell therapy platform development and services, including iPSC and CAR-T related offerings.
13 more services
- AI/ML
- Partnering ecosystem
- Antibodies & Multispecifics
- Monoclonal Discovery
- Multispecific Discovery
- Optimization
- TCR Mimics
- Genetic Medicines
- AntiClastic Cyclic RNA Platform
- Oligonucleotide Design Studio
- Platform access
- Discovery services
- Alloy Ecosystem
- Turnaround
- In as fast as 4 months
- In as little as 3 weeks
- In four weeks
- What to send
- Antigen
- Recombinant proteins
- LNP-encapsulated mRNA
- DNA
- Cell lines
- Binding arms of any type
Capabilities
- Assays and studies
- Antibodies
- Oligonucleotides
- Cell therapy
- Rodent models
- Bispecifics
- In vivo
17 more
- Peptides
- Binding
- Developability
- Function
- Epitope binning
- Cell binding
- In vitro functional testing
- In vivo functional testing
- Cell killing
- Cytokine release
- Internalization
- Pharmacology
- In vivo discovery
- In vitro screening
- Assay development
- Pharmacology studies
- High-throughput screening
- Scale and capacity
- Hundreds of purified antibodies
- Panels of hundreds of clones
- Libraries with billions of variants
- Ml to liter scale
- More than 220 partners
- Over 110 partnered drug programs
3 more
- 24 drugs in the clinic
- 18 new drug companies
- 100+ scientists
- Therapeutic areas
- Oncology
- Infectious disease
- Autoimmune disease
Instruments and platforms
- mAbForge
- ATX-GX
- ATX-GK
- ATX-GL
- ATX-GKH
- ATX-CLC
3 more
- Keyway™
- AntiClastic™
- ReForge
Modalities and species
- Modalities
- Antibody
- Bispecific
- Peptide
- Oligonucleotide
- Cell therapy
- Species and models
- Transgenic mice
- Human heavy chain mouse
- Human kappa light chain mouse
- Human lambda light chain mouse
- Hyperimmune mouse
- Common light chain mouse
11 more
- CHO
- Phage display
- Yeast display
- VHH
- ATX-GK mouse
- ATX-GL mouse
- ATX-Gkh mouse
- ATX-CLC platform
- iPSCs
- CAR-T
- Humanized mouse models
Industries served
- Biotech
- Pharma
- Sovereign organizations
Details
- Founded
- 2017
- Team
- 100+ scientists
- Address
- 275 Second Ave, Suite 200, Waltham, MA 02451
- Sites
- Athens, USA
- Cambridge, UK
- Basel, Switzerland
- Fujisawa, Japan
- Athens, GA, United States
- Cambridge, UK, United Kingdom
- Serves
- Worldwide, U.S. West Coast, Midwest, South, U.S. East Coast, Europe, Asia, Oceania